The Glycosylphosphatidylinositol biosynthesis pathway in human diseases
Abstract Glycosylphosphatidylinositol biosynthesis defects cause rare genetic disorders characterised by developmental delay/intellectual disability, seizures, dysmorphic features, and diverse congenital anomalies associated with a wide range of additional features (hypotonia, hearing loss, elevated...
Main Authors: | Tenghui Wu, Fei Yin, Shiqi Guang, Fang He, Li Yang, Jing Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-020-01401-z |
Similar Items
-
Glycosylphosphatidylinositol-Anchored Proteins in Arabidopsis and One of Their Common Roles in Signaling Transduction
by: Ke Zhou
Published: (2019-08-01) -
Defects in GPI biosynthesis perturb Cripto signaling during forebrain development in two new mouse models of holoprosencephaly
by: David M. McKean, et al.
Published: (2012-07-01) -
Research advances of glycosylphosphatidylinositol-anchored protein LORELEI in plant
by: JIA Mingsheng, et al.
Published: (2020-12-01) -
Interaction of Full-Length Glycosylphosphatidylinositol-Anchored Proteins with Serum Proteins and Their Translocation to Cells In Vitro Depend on the (Pre-)Diabetic State in Rats and Humans
by: Günter A. Müller, et al.
Published: (2021-03-01) -
Significantly different clinical phenotypes associated with mutations in synthesis and transamidase+remodeling glycosylphosphatidylinositol (GPI)-anchor biosynthesis genes
by: Leigh C. Carmody, et al.
Published: (2020-02-01)